tradingkey.logo

Rein Therapeutics Paused Its Phase 2 Renew Trial Of Lti-03 In The U.S.

ReutersJun 12, 2025 9:06 PM

- Rein Therapeutics Inc RNTX.O:

  • REIN THERAPEUTICS : PAUSED ENROLLMENT AND PATIENT DOSING AT ITS CLINICAL TRIAL SITES IN UNITED STATES (U.S.) FOR ITS PHASE 2 RENEW TRIAL OF LTI-03

  • REIN THERAPEUTICS INC - RENEW TRIAL CONTINUES IN AUSTRALIA, UK, AND EUROPE - SEC FILING

  • REIN THERAPEUTICS INC - NO DRUG-RELATED SERIOUS ADVERSE EVENTS REPORTED FOR LTI-03 - SEC FILING

Source text: [ID:n0001193125-25-139950]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI